Salesforce (CRM) Traded Lower Despite Strong Fundamentals
Key takeaways
- Early optimism shifted to a historic energy shock caused by US-Israeli strikes on Iran.
- In its first-quarter 2026 investor letter, Antipodes Global Strategy highlighted Salesforce, Inc.
- Antipodes Global Strategy stated the following regarding Salesforce, Inc.
Salesforce (CRM) Traded Lower Despite Strong Fundamentals Soumya Eswaran Thu, June 25, 2026 at 10:13 PM GMT+7 3 min read CRM Antipodes Partners published its "Antipodes Global Strategy" first-quarter 2026 investor letter, highlighting the key performance stocks, portfolio changes, and the market outlook. A copy of the letter can be downloaded here. The first quarter of 2026 was highly volatile. Early optimism shifted to a historic energy shock caused by US-Israeli strikes on Iran. Global equities dropped 3.2% in USD, with US equities falling 4.6%, and value stocks outperformed growth stocks as the rotation away from mega-cap tech accelerated due to AI fears. The strategy outperformed the benchmark over the quarter and the 12 months to March 31, 2026. Exposure in North America, Korea, Western Europe, and Latin America regions boosted performance, while Canada and the UK lagged. Energy, consumer discretionary, industrials, and healthcare sectors led the performance, while financials, real estate, and materials lagged. To manage risk, the firm increased its holdings in defensive sectors during the quarter. For insights into their key selections for 2026, please review the Strategy's top five holdings.
In its first-quarter 2026 investor letter, Antipodes Global Strategy highlighted Salesforce, Inc. (NYSE:CRM). Salesforce, Inc. (NYSE:CRM) is a cloud computing company that offers Customer Relationship Management (CRM) technology that brings companies and customers together. On June 24, 2026, Salesforce, Inc. (NYSE:CRM) closed at $152.76 per share. One-month return of Salesforce, Inc. (NYSE:CRM) was -13.57%, and its shares lost 42.70% over the past 52 weeks. Salesforce, Inc. (NYSE:CRM) has a market capitalization of $125.65 billion.
Antipodes Global Strategy stated the following regarding Salesforce, Inc. (NYSE:CRM) in its Q1 2026 investor letter: